• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    JanOne Appoints Vay Tham as its Chief Revenue Officer and President of its Fintech Subsidiary, ALT5 Sigma

    6/26/24 7:30:00 AM ET
    $JAN
    Home Furnishings
    Consumer Discretionary
    Get the next $JAN alert in real time by email

    LAS VEGAS, June 26, 2024 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a multidisciplinary organization with a focus on healthcare and fintech, is pleased to announce that it has appointed Mr. Vay Tham as its Chief Revenue Officer and President of ALT5 Sigma, Inc., its wholly-owned subsidiary. Mr. Tham brings extensive experience in capital markets, particularly in technology sectors, spanning over 25 years. His career includes roles in research, investment banking, and finance, notably and most recently as Managing Director and Head of Technology Investment Banking at PI Financial Corp. (Ventum Financial).

    JanOne (PRNewsfoto/JanOne)

    Vay Tham's expertise will be pivotal in leading ALT5 Sigma's go-to-market strategy to educate customers on how to enhance their digital financial ecosystem. He has a background in Electrical Engineering, graduating from the University of Waterloo in 1999, and has previously founded, grown, and successfully sold his own fund, managing over $300 million in assets at the time.

    In this role, Vay will lead ALT5 Sigma's go-to-market strategy, with a focus on expanding the market share of ALT5's leading digital financial ecosystem. Vay Tham, who most recently served as PI Financial Corp.'s (Ventum Financial), Managing Director, Head of Technology Investment Banking, has over 25 years' experience in capital markets. Vay's career has spanned research, investment banking, and finance roles. In addition, Mr. Tham previously founded, grew, and sold his own fund, which had over $300 million of assets under management. Vay has predominantly focused on technology companies throughout his career.

    "Bringing on Vay Tham, a veteran of the financial markets and a technologist at heart, will help drive revenue growth as he focuses on aiding customers in digitizing their legacy financial ecosystems," said Tony Issac, CEO of JanOne. He added, "As our new Chief Revenue Officer, the first in our Company's history, Vay's expertise will be invaluable as we educate our end-users on the breadth of the ALT5 portfolio. Together, with the ALT5 team, we are confident Vay will help us reach new heights."

    Mr. Tham commented, "I am delighted to join JanOne and ALT5. In my 25-year career, I have advised and worked with dozens of corporate entities that would benefit from ALT5's product suite. I look forward to forging new partnerships and building on an already impressive customer base on the ALT5 platform and introducing ALT5 to new opportunities."

    In addition, the Company today announced that, as an inducement grant, on June 25, 2024, our Board of Directors and our Compensation Committee granted Mr. Tham 400,000 restricted stock units (the "RSUs"). The RSUs will vest over two years, subject to certain "Change of Control" accelerators as defined in JanOne's 2023 Plan. Although granted as inducement awards outside of JanOne's 2023 Plan, the RSUs are subject to the terms of that Plan. The RSUs are intended to be inducement awards under Rule 5635(c)(4) of the Nasdaq Stock Market Listing Rules and were granted outside of JanOne's 2023 Plan.

    About ALT5 Sigma Inc.

    Launched in 2018, ALT5 is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5, through its subsidiaries, offers two main platforms to its customers: "ALT5 Pay" and "ALT5 Prime". The Company processed over US$1.2 billion in cryptocurrency transactions in 2023.

    ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. Merchants have the option to convert to fiat currency (s) automatically or to receive their payment in digital assets.

    ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through a browser-based access mobile phone application named "ALT5 Pro" that can be downloaded from the Apple App Store, from Google Play, through ALT5 Prime's FIX API, as well as through Broadridge Financial Solutions' NYFIX gateway for approved customers.

    About JanOne

    JanOne is a unique Nasdaq-listed multidisciplinary organization with a focus on healthcare and fintech. JanOne is one of the constituents of the Russell Microcap Index, starting June 28, 2024. Through its biotech activities, JanOne is developing innovative, actionable solutions intended to help end the opioid crisis. JanOne is dedicated to funding resources toward innovation, technology, and education to find a key resolution to the national opioid epidemic, which is one of the deadliest and most widespread in the nation's history. Its drugs in the clinical trial pipeline have shown promise for their innovative targeting of the causes of pain as a strategic option for physicians averse to exposing patients to addictive opioids.

    JanOne's ALT5 subsidiary is a global fintech that provides next generation blockchain powered technologies for the trading, clearing, settlement, payment, and custodianship of digital instruments.

    Please visit www.janone.com for additional information.

    Forward Looking Statements

    This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the statements that JAN 101 will treat PAD, that JAN 123 will treat CRPS, the timing of the commencement of clinical trials, that the FDA will permit approval through a 505(b)(2) pathway for JAN 123, that upon approval JAN 101 will immediately disrupt the PAD market, and other statements, including words such as "continue", "expect", "intend", "will", "hope" "should", "would", "may", "potential", and other similar expressions. This press release also contains statements and links relating to the profitability and prospective growth of ALT5's platforms and business, including, but not limited to international currency risks, third-party or customer credit risks, liability claims stemming from ALT5's services, and technology challenges for future growth or expansion. Such statements reflect JanOne's current view with respect to future events, are subject to risks and uncertainties, and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by JanOne, are inherently subject to significant business, economic, competitive, political, and social uncertainties and contingencies.

    Many factors could cause JanOne's actual results, performance, or achievements to be materially different from any future results, performance or achievements described in this press release. Such factors could include, among others, those detailed in the Company's periodic reports filed with the Securities and Exchange Commission (the "SEC"). Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled "Risk Factors" in JanOne's filings with the SEC underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and JanOne does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. JanOne cannot assure that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.

    Media Contact Investor Relations

    [email protected]

    1-800-400-2247

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/janone-appoints-vay-tham-as-its-chief-revenue-officer-and-president-of-its-fintech-subsidiary-alt5-sigma-302182550.html

    SOURCE JanOne Inc.

    Get the next $JAN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $JAN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $JAN
    Financials

    Live finance-specific insights

    See more
    • JanOne Announces Plan to Enhance Stockholder Value Through Strategic Realignment

      -The board has approved a strategic review of the biotech assets and ALT5 Sigma being the core focus going forward- -The company is intending a name and stock symbol change to reflect this decision- LAS VEGAS, July 10, 2024 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a multidisciplinary organization with a focus on fintech and healthcare, has announced plans to enhance stockholder value through a visionary strategic realignment, entailing a redeployment of biotech assets and a change of its name. The plan, unanimously approved by the company's board and following the May acquisi

      7/10/24 8:30:00 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • JanOne Inc. Completes Acquisition of Soin Therapeutics, LLC

      The acquisition of Soin provides JanOne with its second, late stage clinical stage asset LAS VEGAS, Jan. 10, 2023 /PRNewswire/ -- JanOne Inc. ("JanOne") (NASDAQ:JAN), a company that focuses on the development of drugs with non-addictive, pain-relieving properties, announced today that it has completed the acquisition of Soin Therapeutics, LLC and its product, a patent-pending, novel formulation of low-dose naltrexone. This all stock transaction has a value of $13M, with up to an additional $17M depending on revenues generated by the product, for a total value of up to $30M. The transaction includes restrictions on the maximum number of shares of preferred stock and common stock that can be i

      1/10/23 8:30:00 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • JanOne Inc. Acquires an Option for the Rights to a Worldwide, Exclusive License for a Novel Strategy for Treating Methamphetamine Use Disorder

      LAS VEGAS, Dec. 7, 2021 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company that focuses on the development of drugs with non-addictive, pain-relieving properties - in an effort to further reduce the drug addiction epidemic - today announced an option agreement for the rights to a novel strategy to reduce methamphetamine (meth) use by activating the Translocator Protein 18 kDa (TSPO).  The agreement with LSU Health Shreveport, along with other intellectual property relating to TSPO's role in treating meth use disorder (MUD), provides JanOne Inc. with an opportunity to identify new drugs to enhance TSPO activity, and by doing so, reducing craving for meth. This new strategy for treating MUD w

      12/7/21 9:00:00 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary

    $JAN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ALT5 Sigma Corporation Partners With Hashtag Influencer to Enable Cryptocurrency Payment Processing for Influencer Marketing

      LAS VEGAS, NV / ACCESSWIRE / January 15, 2025 / ALT5 Sigma Corporation (NASDAQ:ALTS), a prominent innovator in the cryptocurrency sector, is pleased to announce a partnership with Hashtag Influencer, an advanced AI-powered SocialFi platform. This collaboration aims to enhance the influencer marketing landscape by enabling influencers in the gig economy to seamlessly and compliantly accept cryptocurrency payments for advertising deals with brands through social media platforms such as Instagram, Facebook, YouTube, and LinkedIn."While much attention has been given to the adoption of blockchain by traditional institutions, collaborating with innovators such as Hashtag Influencer-a forthcoming A

      1/15/25 7:00:00 AM ET
      $ALTS
      $JAN
      Home Furnishings
      Consumer Discretionary
    • Alyea Therapeutics to Present at Biotech Showcase 2025 During 43rd Annual J.P. Morgan Healthcare Conference Week

      Finalist to present at RESI JPM IPC and attend the Nasdaq Opening Bell Ceremony on January 13 LAS VEGAS, NV / ACCESSWIRE / January 10, 2025 / Alyea Therapeutics Corporation Inc. ("Alyea" or the "Company"), a subsidiary of Alt 5 Sigma Corporation (NASDAQ:ALTS), announced today its engagement in key events during the 43rd Annual J.P. Morgan Healthcare Conference Week, to be held on January 13-16, 2025, in San Francisco, California. Alyea is developing innovative, actionable solutions intended to help end the opioid crisis with its lead asset ("JAN123"), a novel formulation of Low Dose Naltrexone ("LDN"), preparing for its pivotal Phase III study. Having already been granted Orphan Drug designa

      1/10/25 8:30:00 AM ET
      $ALTS
      $JAN
      Home Furnishings
      Consumer Discretionary
    • ALT5 Sigma to Exhibit at iFX EXPO Dubai January 14-16, 2025

      LAS VEGAS, NV / ACCESSWIRE / January 9, 2025 / ALT5 Sigma Corporation (NASDAQ:ALTS), a fintech, providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, announced its participation in the upcoming iFX EXPO Dubai.ALT5 will be exhibiting through the three days of the show at the Dubai World Trade Centre, providing product demonstrations, solutions and general information to many of the 7,000+ attendees starting January 14th in booth #26.iFX EXPO Dubai 2025 is the ultimate meeting place for brokers, affiliates, traders, investors, and tech- and service-providers who are looking to succeed in the MENA

      1/9/25 11:30:00 AM ET
      $ALTS
      $JAN
      Home Furnishings
      Consumer Discretionary

    $JAN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Isaac Antonios was granted 125,787 shares, increasing direct ownership by 137% to 217,787 units

      4 - JanOne Inc. (0000862861) (Issuer)

      1/9/23 4:30:05 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • SEC Form 4: Johnson Virland A was granted 78,617 shares

      4 - JanOne Inc. (0000862861) (Issuer)

      1/9/23 4:20:58 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • SEC Form 4: Johnson Virland A sold $220,651 worth of Common Shares (32,933 units at $6.70), decreasing direct ownership by 100% to 0 units

      4 - JanOne Inc. (0000862861) (Issuer)

      5/26/21 4:02:12 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary

    $JAN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by JanOne Inc. (Amendment)

      SC 13G/A - JanOne Inc. (0000862861) (Subject)

      8/24/23 4:30:55 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • SEC Form SC 13G filed by JanOne Inc.

      SC 13G - JanOne Inc. (0000862861) (Subject)

      3/27/23 9:00:21 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • SEC Form SC 13G/A filed by JanOne Inc. (Amendment)

      SC 13G/A - JanOne Inc. (0000862861) (Subject)

      2/11/22 6:07:45 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary

    $JAN
    SEC Filings

    See more
    • JanOne Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - ALT5 Sigma Corp (0000862861) (Filer)

      7/17/24 2:55:12 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • JanOne Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - JanOne Inc. (0000862861) (Filer)

      6/21/24 5:22:48 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • SEC Form 424B5 filed by JanOne Inc.

      424B5 - JanOne Inc. (0000862861) (Filer)

      6/21/24 5:20:23 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary

    $JAN
    Leadership Updates

    Live Leadership Updates

    See more
    • ALT5 Sigma Welcomes FinTech Executive, Ron Pitters to Its Board of Directors

      LAS VEGAS, NV / ACCESSWIRE / November 6, 2024 / ALT5 Sigma Corporation (NASDAQ:ALTS) ("ALT5" or the "Company"), a fintech innovator providing next-generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and secure storage of digital assets, is pleased to announce the appointment of Mr. Ron Pitters to its Board of Directors."We are thrilled to welcome industry veteran, Ron Pitters, to our Board. With a unique blend of experience in both traditional finance and disruptive blockchain technologies, Ron brings invaluable insights. His proven track record, spanning from startups to multinational corporations, makes him a fantastic addition to our team,"

      11/6/24 8:30:00 AM ET
      $ALTS
      $JAN
      Home Furnishings
      Consumer Discretionary
    • JanOne Appoints Vay Tham as its Chief Revenue Officer and President of its Fintech Subsidiary, ALT5 Sigma

      LAS VEGAS, June 26, 2024 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a multidisciplinary organization with a focus on healthcare and fintech, is pleased to announce that it has appointed Mr. Vay Tham as its Chief Revenue Officer and President of ALT5 Sigma, Inc., its wholly-owned subsidiary. Mr. Tham brings extensive experience in capital markets, particularly in technology sectors, spanning over 25 years. His career includes roles in research, investment banking, and finance, notably and most recently as Managing Director and Head of Technology Investment Banking at PI Financial Corp. (Ventum Financial).

      6/26/24 7:30:00 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • JanOne Appoints Internationally Renowned Expert on Addiction Nicholas Goeders, Ph.D. to Scientific Advisory Board

      LAS VEGAS, June 15, 2021 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced the appointment of Nicholas E. Goeders, Ph.D. to its Scientific Advisory Board (SAB). Dr. Goeders is considered one of the world's leaders on the role of stress in drug addiction.  Tony Isaac, President and Chief Executive Officer of JanOne, commented, "JanOne's mission is to develop non-addictive medications to treat diseases that cause severe pain, thereby m

      6/15/21 10:15:00 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary